Company News, Packaging News

CCL Industries Reviews Investment in Miza

CCL Industries, Toronto, Canada, is re-viewing its options in its approximately $22 million investment in Miza Pharmaceuticals. In May of 2001, CCL sold its non-core UK custom manufacturing pharmaceutical business to Miza for subordinated convertible notes and an equity interest in Miza.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters